vs
Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and PCB BANCORP (PCB). Click either name above to swap in a different company.
PCB BANCORP is the larger business by last-quarter revenue ($29.2M vs $27.6M, roughly 1.1× Beta Bionics, Inc.). On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs 11.3%).
Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
BBNX vs PCB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $29.2M |
| Net Profit | $-21.9M | — |
| Gross Margin | 59.5% | — |
| Operating Margin | -47.4% | 45.0% |
| Net Margin | -79.3% | — |
| Revenue YoY | 56.6% | 11.3% |
| Net Profit YoY | 23.6% | — |
| EPS (diluted) | $-0.49 | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $27.6M | — | ||
| Q4 25 | $32.1M | $29.2M | ||
| Q3 25 | $27.3M | $30.4M | ||
| Q2 25 | $23.2M | $29.3M | ||
| Q1 25 | $17.6M | $26.9M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | — | $25.3M | ||
| Q2 24 | — | $24.2M |
| Q1 26 | $-21.9M | — | ||
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-14.2M | $11.4M | ||
| Q2 25 | $-16.9M | $9.1M | ||
| Q1 25 | $-28.7M | $7.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $6.3M |
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.0% | — | ||
| Q3 25 | 55.5% | — | ||
| Q2 25 | 53.8% | — | ||
| Q1 25 | 50.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | -47.4% | — | ||
| Q4 25 | -50.2% | 45.0% | ||
| Q3 25 | -62.5% | 52.3% | ||
| Q2 25 | -85.5% | 43.3% | ||
| Q1 25 | -105.7% | 40.2% | ||
| Q4 24 | — | 39.3% | ||
| Q3 24 | — | 42.2% | ||
| Q2 24 | — | 36.3% |
| Q1 26 | -79.3% | — | ||
| Q4 25 | -41.9% | — | ||
| Q3 25 | -52.1% | 37.5% | ||
| Q2 25 | -72.6% | 31.0% | ||
| Q1 25 | -162.5% | 28.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 30.8% | ||
| Q2 24 | — | 25.9% |
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-0.16 | $0.65 | ||
| Q3 25 | $-0.33 | $0.78 | ||
| Q2 25 | $-0.39 | $0.62 | ||
| Q1 25 | $-0.93 | $0.53 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $0.52 | ||
| Q2 24 | — | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $199.5M | $207.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $271.2M | $390.0M |
| Total Assets | $304.4M | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $199.5M | — | ||
| Q4 25 | $219.1M | $207.1M | ||
| Q3 25 | $228.7M | $369.5M | ||
| Q2 25 | $249.7M | $263.6M | ||
| Q1 25 | $231.5M | $214.3M | ||
| Q4 24 | — | $198.8M | ||
| Q3 24 | — | $193.1M | ||
| Q2 24 | — | $177.6M |
| Q1 26 | $271.2M | — | ||
| Q4 25 | $287.6M | $390.0M | ||
| Q3 25 | $294.8M | $384.5M | ||
| Q2 25 | $301.6M | $376.5M | ||
| Q1 25 | $313.8M | $370.9M | ||
| Q4 24 | — | $363.8M | ||
| Q3 24 | — | $362.3M | ||
| Q2 24 | — | $353.5M |
| Q1 26 | $304.4M | — | ||
| Q4 25 | $328.7M | $3.3B | ||
| Q3 25 | $330.0M | $3.4B | ||
| Q2 25 | $330.0M | $3.3B | ||
| Q1 25 | $338.0M | $3.2B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $26.6M |
| Free Cash FlowOCF − Capex | — | $24.4M |
| FCF MarginFCF / Revenue | — | 83.6% |
| Capex IntensityCapex / Revenue | — | 7.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-8.6M | $26.6M | ||
| Q3 25 | $-8.7M | $16.4M | ||
| Q2 25 | $-13.6M | $4.9M | ||
| Q1 25 | $-20.0M | $2.3M | ||
| Q4 24 | — | $39.0M | ||
| Q3 24 | — | $11.9M | ||
| Q2 24 | — | $14.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-10.5M | $24.4M | ||
| Q3 25 | $-10.0M | $16.2M | ||
| Q2 25 | $-15.4M | $3.8M | ||
| Q1 25 | $-20.3M | $1.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | — | $11.9M | ||
| Q2 24 | — | $12.8M |
| Q1 26 | — | — | ||
| Q4 25 | -32.8% | 83.6% | ||
| Q3 25 | -36.7% | 53.2% | ||
| Q2 25 | -66.2% | 13.1% | ||
| Q1 25 | -115.1% | 6.0% | ||
| Q4 24 | — | 133.2% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 53.1% |
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | 7.5% | ||
| Q3 25 | 4.7% | 0.8% | ||
| Q2 25 | 7.7% | 3.7% | ||
| Q1 25 | 1.9% | 2.8% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 7.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 2.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
